In the pivotal clinical trial of their technology, researchers at Orlucent®, Inc. have confirmed the accuracy of the company's Skin Fluorescent Imaging (SFI) System, a non-invasive, hand-held ...

Bayer, a leading company in key areas of radiology and cardiology, and Attralus, Inc. (Attralus), a clinical stage biopharmaceutical company focused on developing medicines and diagnostics for ...

Bayer is acquiring two investigational molecular imaging agents from Attralus for the diagnosis of cardiac amyloidosis.

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and ...

A study in Nature Cardiovascular Research by researchers at Washington University School of Medicine in St. Louis explores a new, noninvasive imaging technique that helps scientists visualize immune ...

A newly developed radiopharmaceutical pair can precisely detect and effectively treat--completely eradicating tumors in ...

Plasmonic nanogap confinement extends sum frequency vibrational spectroscopy to the nanoscale, enabling direct imaging of ...

Advances in Total-Body PET/CT Research. Journal of Biosciences and Medicines, 14, 274-282. doi: 10.4236/jbm.2026.141021 . PET ...

Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of protein drugs known as DARPin therapeutics ...

A new fluorescent imaging probe can for the first time objectively and non-invasively measure loss of smell, clinically known as anosmia. Targeting the olfactory nerve, the new tool has potential to ...